Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
2020-12-01 to 2021-11-30 |
As at 2021-11-30 |
As at 2020-11-30 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification |
Heidelberg Pharma AG
|
— | — |
| Domicile of entity |
Ladenburg nahe Heidelberg, Deutschland
|
— | — |
| Legal form of entity |
AG
|
— | — |
| Country of incorporation |
Deutschland
|
— | — |
| Address of entity's registered office |
Gregor-Mendel-Straße 22 in 68526 Ladenburg nahe Heidelberg
|
— | — |
| Description of nature of entity's operations and principal activities |
arbeitet im Wesentlichen in den Bereichen Konzern-
|
— | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories | — |
746
EUR
|
230
EUR
|
| Current trade receivables | — |
1.019.751
EUR
|
1.187.684
EUR
|
| Current trade payables | — |
903
EUR
|
2.811.832
EUR
|